Cimlanod

N/A

Report date: 2025/01/09 20:00:05
NME

Base Information

Drug NameCimlanod
Drug Alias NameHNO Nitroxyl DonorHNO DonorBMS-986231CXL-1427BMS-986231-01
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNitric oxide donors
TargetsNot applicable
Therapy Area/IndicationsLiver DysfunctionHeart FailureRenal Insufficiency +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[16
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsLiver DysfunctionHeart FailureRenal Insufficiency +[5

Other Information

ATC CodeN/A
Related LinksN/A